Clinical Trial: Add-on Reparixin in Adult Patients With ARDS
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Respiratory Distress Syndrome, Adult
Study Type: INTERVENTIONAL
Official Title: Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as add-on Therapy to SoC in Acute Respiratory Distress Syndrome (RESPIRATIO)
Brief Summary:
Study objectivesTo characterize the efficacy of reparixin in ameliorating lung injury and systemic inflammation and expediting clinical recovery and liberation from mechanical ventilation in adult patients with moderate to severe ARDS (PaO2/FIO2 ratio ? 200).To evaluate the safety of reparixin vs. placebo in patients enrolled in the study.
Read more